Not affiliated with the Wisconsin Legislature · an independent reference by Fifty Domes

PlansSign in

Bills › 2025 to 2026 Legislature › State Senate bill

SB 10322025 to 2026
bill

2025 to 2026 Legislature · State Senate bill

SB 1032

Relating to: a sales and use tax exemption for the sale of over-the-counter drugs. (FE)

In committee Last action March 23, 2026: Failed to pass pursuant to Senate Joint Resolution 1

Official bill page and text: docs.legis.wisconsin.gov

Sponsors 6

Prime sponsors
Carpenter, Hesselbein, Ratcliff, Smith, Spreitzer, Wirch

Status

In committee as of March 23, 2026. The 2025 to 2026 Legislature serves until the 2027 Legislature convenes on January 4, 2027.

Referred to: Senate Agriculture and Revenue (from the official referral record)

Roll-call votes 0

No roll-call votes recorded for this measure.

Timeline 7

DateChamberAction
March 23, 2026SenateFailed to pass pursuant to Senate Joint Resolution 1
March 19, 2026SenateRepresentative J. Jacobson added as a cosponsor
March 18, 2026SenateRepresentative Anderson added as a cosponsor
March 13, 2026SenateSenator Keyeski added as a coauthor
March 4, 2026SenateFiscal estimate received
February 17, 2026SenateRead first time and referred to Committee on Agriculture and Revenue
February 17, 2026SenateIntroduced by Senators Smith, Wirch, Carpenter, Ratcliff, Hesselbein and Spreitzer; cosponsored by Representatives Sheehan, Sinicki, Snodgrass, Joers, Hysell, Miresse, Stubbs, Palmeri, Johnson, Roe and Neubauer

Data: Open States (bulk data, October 1, 2026 monthly extract, which has no roll-call tallies; public data, attribution appreciated). Official record: docs.legis.wisconsin.gov. Bill pages link to the official text, not copied.

Sources for this page

Bill, action and roll-call data from Open States (public data, attribution appreciated). Neither Wisconsin Capitol Guide nor this information, as presented here, is endorsed by the Wisconsin Legislature.